Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body
- Status
- TERMINATED
- Phase
- PHASE1
Nevus Doctor Clinical Decision Support
- Status
- COMPLETED
- Phase
- NA
Integrated Cancer Repository for Cancer Research
- Status
- RECRUITING
- Phase
- N/A
Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
- Status
- TERMINATED
- Phase
- NA
Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma
- Status
- COMPLETED
- Phase
- N/A
LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)
- Status
- TERMINATED
- Phase
- PHASE2
A Two-arm, Single Center Phase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma Patients
- Status
- TERMINATED
- Phase
- PHASE1
MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study
- Status
- UNKNOWN
- Phase
- PHASE2
Vemurafenib Plus Cobimetinib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma
- Status
- RECRUITING
- Phase
- PHASE1